Citation 145606

CORTES,D: FIGADERE,B: SAEZ,J: PROTAIS,P:. (1992). DISPLACEMENT ACTIVITY OF BISBENZYLISOQUINOLINE ALKALOIDS AT STRIATAL 3H-SCH 23390 AND 3H-RACLOPRIDE BINDING SITES.. 55(9)

Citation Details

Title	DISPLACEMENT ACTIVITY OF BISBENZYLISOQUINOLINE ALKALOIDS AT STRIATAL 3H-SCH 23390 AND 3H-RACLOPRIDE BINDING SITES.
Authors	CORTES,D: FIGADERE,B: SAEZ,J: PROTAIS,P:
Year	1992
Volume	55
Issue	9

Summary

Year: 1992

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ABSOLUTE CONFIGURATION DETERMINEDCD SPECTRUM REPORTED FOR	BERBAMUNINE,(R-S):THALIGRISINE,(R-S):GRISABINE,O-O-DIMETHYL: (S-R):PAMPULHAMINE,(R-R):DAURICINE,O-METHYHL: (R-R):	None
2	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	THALIGRISINE,(R-S):	ACTIVE
3	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	THALIGRISINE,(R-S):	ACTIVE
4	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	BERBAMUNINE,(R-S):	ACTIVE
5	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	BERBAMUNINE,(R-S):	ACTIVE
6	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	GRISABINE,O-O-DIMETHYL: (S-R):	ACTIVE
7	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	GRISABINE,O-O-DIMETHYL: (S-R):	ACTIVE
8	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	PAMPULHAMINE,(R-R):DAURICINE,O-METHYHL: (R-R):	INACTIVE
9	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	PAMPULHAMINE,(R-R):DAURICINE,O-METHYHL: (R-R):ANTIOQUINE,(S-R):LUCIDINE,SECO: (S):	INACTIVE
10	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	AROMOLINE,HOMO: (R-S):	ACTIVE
11	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	AROMOLINE,HOMO: (R-S):	ACTIVE
12	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	TETRANDRINE,ISO: (S-R):	ACTIVE
13	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	TETRANDRINE,ISO: (S-R):	ACTIVE
14	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	OBABERINE,(R-S):	ACTIVE
15	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	OBABERINE,(R-S):	ACTIVE
16	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	OXANDRINE,(S-S):	ACTIVE
17	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	OXANDRINE,(S-S):	ACTIVE
18	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	XANDRINE,PSEUDO: DIMETHYL: (S-R):	ACTIVE
19	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	XANDRINE,PSEUDO: DIMETHYL: (S-R):	ACTIVE
20	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	XANDRINE,PSEUDO: (S-R):	ACTIVE
21	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	XANDRINE,PSEUDO: (S-R):	ACTIVE
22	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIOQUINE,(S-R):	ACTIVE
23	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	OBABERINE,SECO: (S):ANTIOQUINE,SECO: (S):	INACTIVE
24	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	OBABERINE,SECO: (S):	INACTIVE
25	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIOQUINE,SECO: (S):	ACTIVE
26	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	LUCIDINE,SECO: (S):	ACTIVE

Citation 145606

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1